FDA's CBD Docket Comments: Harm Reduction To Churches, 'More Humane' Medication To 'Source Of Confusion'

Consumers' submissions, many with anonymous attribution, account for most of the 776 comments FDA has received to its "Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds" docket. Few provide data or other information FDA asks for and some organizations' comments align with consumers by focusing on sentiment and appreciation.

US map-cannibis-plants

More from Regulation

More from Policy & Regulation